Back to top
more

Clorox (CLX)

(Real Time Quote from BATS)

$163.07 USD

163.07
401,474

+0.37 (0.23%)

Updated Nov 7, 2024 01:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 15% (37 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Clorox Stock Gains 3.8% in a Week on Solid Q1 Results: Buy or Avoid?

by Zacks Equity Research

CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.

Santanu Roy headshot

Beat the Market the Zacks Way: Bank of New York Mellon, PetMed, Ulta Beauty in Focus

by Santanu Roy

Our time-tested methodologies helped investors navigate the market well last week. Here are some of our key performance data from the past three months.

CHD Q3 Earnings Beat, Robust Consumer Demand Drives Sales Growth

by Zacks Equity Research

Church & Dwight's Q3 results reflect increased sales and earnings on strong consumer demand, resilience of its brands and successful new product launches.

CLX Q1 Earnings & Sales Beat Estimates, Raised FY25 View Drives Stock

by Zacks Equity Research

Clorox's Q1 results reflect a recovery from last year's cyberattack-related woes. Organic sales across all segments and margin expansion boost its performance.

Clorox (CLX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Clorox (CLX) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of 36.76% and 8.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Will Soft Ag Services & Oilseeds Performance Mar ADM's Q3 Earnings?

by Zacks Equity Research

Archer Daniels' Q3 results are expected to reflect continued weak trends in the Agricultural Services & Oilseeds segment, and soft crush margins.

AB InBev to Post Q3 Earnings: Essential Insights Ahead of the Report

by Zacks Equity Research

BUD's Q3 results are expected to reflect the benefits of premiumization efforts, its diverse brand portfolio, pricing strategies and revenue management plans.

Church & Dwight to Report Q3 Earnings: Here's What You Should Know

by Zacks Equity Research

CHD's robust brand equity, commitment to innovation and new products set it up for a decent Q3 sales result despite a challenging consumer spending landscape.

Clorox (CLX) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Clorox (CLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Clorox Gears Up for Q1 Earnings: Here's What You Should Know

by Zacks Equity Research

CLX's first-quarter fiscal 2025 results are likely to gain from pricing and cost-saving efforts. It aims at innovation and brand building.

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

EL Gears Up for Q1 Earnings Release: Here's What You Should Know

by Zacks Equity Research

EL's fiscal first-quarter results are likely to reflect difficulties in mainland China and Asia travel retail due to persistently weak consumer sentiment.

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for NOBL

Colgate Beats Q3 Earnings & Sales Estimates, Raises 2024 View

by Zacks Equity Research

CL's Q3 results reflect continued gains from volume and pricing, which led to organic sales growth in five of six divisions. Improved margins aid EPS growth.

Earnings Preview: Church & Dwight (CHD) Q3 Earnings Expected to Decline

by Zacks Equity Research

Church & Dwight (CHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Colgate-Palmolive (CL) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Colgate-Palmolive (CL) delivered earnings and revenue surprises of 3.41% and 0.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

The Kraft Heinz Company Q3 Earnings Coming Up: Factors to Watch

by Zacks Equity Research

KHC's Q3 results are likely to reflect struggles related to a difficult consumer environment, while pricing should aid margins.

Sysco's Q1 Earnings Coming Up: Here's What You Should Know

by Zacks Equity Research

SYY's Q1 results are expected to show growth in its Food-Away-From-Home sector, alongside enhanced efficiency driven by supply-chain productivity improvements.

Service Corporation Prepares for Q3 Earnings: What Should You Know?

by Zacks Equity Research

SCI's Q3 results are likely to reflect strength in the Cemetery segment, while Funeral unit revenues have been soft for a while.

Ritujay Ghosh headshot

5 Low-Beta Defensive Stocks to Sail Through Ongoing Market Volatility

by Ritujay Ghosh

Low-beta utility and consumer staple stocks like AEP, AWK, FTS, CLX and DEO are safe bets during times of market volatility.

RBGLY or CLX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

RBGLY vs. CLX: Which Stock Is the Better Value Option?

Clorox (CLX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mondelez Q3 Earnings Coming Up: Is a Beat in Store for MDLZ Stock?

by Zacks Equity Research

Mondelez's Q3 results are likely to reflect gains from brand strength, especially in the core chocolate and biscuit categories.